API`S R&D Research & Development

Optimus has a strong R&D infrastructure, and 110+ scientists are supporting R&D activities including Synthesis, Analytical, Intellectual Property and DQA. At Optimus, emphasis on an innovative approach is the key value driver for new products development. Our R&D capabilities of innovative process development, cost-effective technology development and stronghold on chiral chemistry have helped us to become the partner of choice for many global players in the industry.

At Optimus, we believe that R&D is the foundation for the harmonious growth of any organization, and we value research & innovation more than any other activity. The R&D expertise has enabled us to develop complex & niche products that give us an edge over the competitors. Our R&D is well equipped with the infrastructure that supports advanced research and innovation, our team continuously thrives for the development of NDA and process innovation with the approach of knowledge-driven research.

Well equipped with Infrastructure

Optimus R&D centre CSIR approved state-of-art facility equipped with the right infrastructure and technology which enables us in executing R&D activities effectively & efficiently. Optimus R&D efforts & activities are aligned with its organisational goal of providing quality products at affordable prices for the people in need.

Dedicated R&D centres for:

  • Oncology
  • Generic APIs

Reaction Capabilities

  • Birch Reduction
  • Clemmensen Reduction
  • Curtius Rearrangement (Reaction)
  • Diels-Alder Reaction
  • Friedel-Crafts Acylation
  • Gabriel Synthesis
  • Grignard Reaction
  • Mitsunobu Reaction
  • Suzuki Coupling
  • Wolff-Kishner Reduction
  • Wittig Reaction & Many Others…

R&D Highlights

Laboratories

Well-equipped laboratories

Professional Scientists

Professional scientists provide an end to
end solution consisting

Labs

Well-equipped analytical labs including
HPLCs, GCs etc. complying 21 CFR.

Analytical Validations

Conducting all types of analytical
validations required for regulatory
submissions.